Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moia

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Clinical Pharmacology and Therapeutics|March 6, 2004
CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapyFlora Peyvandi, Marta Spreafico, Simona Maria Siboni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 30, 2016
Coagulation parameters in patients with cirrhosis and portal vein thrombosis treated sequentially with low molecular weight heparin and vitamin K antagonistsArmando Tripodi, Massimo Primignani, Simon Braham, et al.
Human Vaccines & Immunotherapeutics|October 13, 2021
The effect of health literacy on vaccine hesitancy among Italian anticoagulated population during COVID-19 pandemic: the moderating role of health engagementArianna Magon, Cristina Arrigoni, Guendalina Graffigna, et al.
Internal and Emergency Medicine|November 6, 2009
Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysisStefano Capri, Walter Ageno, Davide Imberti, et al.
Internal and Emergency Medicine|June 11, 2011
Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master RegistryWalter Ageno, Giancarlo Agnelli, Davide Imberti, et al.
Health and Quality of Life Outcomes|March 18, 2020
Determinants of health-related quality of life: a cross-sectional investigation in physician-managed anticoagulated patients using vitamin K antagonistsArianna Magon, Cristina Arrigoni, Marco Moia, et al.
Haematologica|January 29, 2008
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER RegistryDavide Imberti, Giancarlo Agnelli, Walter Ageno, et al.
Thrombosis Research|May 16, 2012
Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registryMelina Verso, Giancarlo Agnelli, Walter Ageno, et al.
Thrombosis and Haemostasis|January 25, 2008
A commentary: to screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registryGualtiero Palareti, Giancarlo Agnelli, Davide Imberti, et al.
Thrombosis Research|August 19, 2007
The MASTER registry on venous thromboembolism: description of the study cohortGiancarlo Agnelli, Melina Verso, Walter Ageno, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Clinical Pharmacology and Therapeutics|March 6, 2004
CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapyFlora Peyvandi, Marta Spreafico, Simona Maria Siboni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 30, 2016
Coagulation parameters in patients with cirrhosis and portal vein thrombosis treated sequentially with low molecular weight heparin and vitamin K antagonistsArmando Tripodi, Massimo Primignani, Simon Braham, et al.
Human Vaccines & Immunotherapeutics|October 13, 2021
The effect of health literacy on vaccine hesitancy among Italian anticoagulated population during COVID-19 pandemic: the moderating role of health engagementArianna Magon, Cristina Arrigoni, Guendalina Graffigna, et al.
Internal and Emergency Medicine|November 6, 2009
Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysisStefano Capri, Walter Ageno, Davide Imberti, et al.
Internal and Emergency Medicine|June 11, 2011
Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master RegistryWalter Ageno, Giancarlo Agnelli, Davide Imberti, et al.
Health and Quality of Life Outcomes|March 18, 2020
Determinants of health-related quality of life: a cross-sectional investigation in physician-managed anticoagulated patients using vitamin K antagonistsArianna Magon, Cristina Arrigoni, Marco Moia, et al.
Haematologica|January 29, 2008
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER RegistryDavide Imberti, Giancarlo Agnelli, Walter Ageno, et al.
Thrombosis Research|May 16, 2012
Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registryMelina Verso, Giancarlo Agnelli, Walter Ageno, et al.
Thrombosis and Haemostasis|January 25, 2008
A commentary: to screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registryGualtiero Palareti, Giancarlo Agnelli, Davide Imberti, et al.
Thrombosis Research|August 19, 2007
The MASTER registry on venous thromboembolism: description of the study cohortGiancarlo Agnelli, Melina Verso, Walter Ageno, et al.
Pageof 5